NCT03016091 2025-02-18
A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma
Rabin Medical Center
Phase 2 Terminated
Rabin Medical Center
Abramson Cancer Center at Penn Medicine
Sarcoma Alliance for Research through Collaboration